Rheumatoid arthritis patients using adalimumab don’t face higher risks for adverse health events, researchers said in a recent study. The new study also reinforces the benefit for these patients of receiving the flu vaccine.
(ACR 2014) A drug with a novel mechanism, sifalimumab, shows promise against lupus. In a video interview, Munther Khamastha MD describes the latest research into what could become a second new option for lupus patients.
Positioning of the probe is "three-quarters of the battle" in diagnosing synovitis of the wrist or hand, says Dr. DeMarco in this video. But gel technique and pressure are crucial to gaining accurate clinical information from ultrasound imaging of this condition.